Ideaya Biosciences Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | -163.6% | – | – | – | |
| – | -0.2% | +5.7% | +1.4% | -7.7% | -36.5% | +76.2% | +8.8% | -16.5% | +16.2% | -4.5% | +98.1% | – | |
| – | -9.5% | +31.6% | +54.2% | -5.3% | +2.9% | +7.9% | +15.9% | +2.9% | -3.5% | +23.3% | +114.6% | – | |
| – | – | -164.4% | – | -114.5% | – | +23.2% | +8.6% | +154.0% | -259.7% | – | +84.0% | – | |
| – | +39.0% | +58.1% | -26.6% | -53.0% | +141.1% | +20.7% | -50.2% | -93.7% | +692.9% | +190.4% | +89.6% | – | |
| – | -318.0% | – | – | -129.2% | +883.8% | – | -42.5% | -9.0% | -333.5% | – | -131.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +406.2% | +147.8% | -88.8% | +631.2% | -99.0% | +849.6% | -95.4% | -75.0% | +607.6% | -44.6% | +30,415.7% | – | |
| – | -87.9% | -921.5% | – | +190.2% | -245.5% | – | -133.7% | – | -201.0% | – | +258.0% | – | |
| – | – | – | – | – | – | – | – | – | -163.9% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.